Japan gov't panel approves 2 iPS-derived drugs

**This is a 60-seconds sample of the video. For the full version, please contact us.**

Japan gov't panel approves 2 iPS-derived drugs

OSAKA, Japan, Feb. 19 Kyodo - University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university. (Kyodo)

  • Product Code
  • ILEA005072051
  • Registered date
  • 2026/2/19 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Kyodo News
  • Media size
  • 1920 × 1080 pixel
  • Deployment size
  • 87.39(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Use of iPS cells to treat spinal cord injuries

    Use of iPS cells to treat spinal cord injuries

    Keio University professors Hideyuki Okano (L) and Masaya Nakamura, who together lead a project to use iPS cells to treat patients with spinal cord injuries, attend a press conference in Tokyo on Feb. 18, 2019, following the Japanese health ministry's approval of a clinical study of the project. (Kyodo) ==Kyodo
      Use of iPS cells to treat spinal cord injuries

      Use of iPS cells to treat spinal cord injuries

      Keio University professor Hideyuki Okano, who leads a project to use iPS cells to treat patients with spinal cord injuries, speaks at a press conference in Tokyo on Feb. 18, 2019, following the Japanese health ministry's approval of a clinical study of the project. (Kyodo) ==Kyodo
        Osaka hospital succeeds in novel heart valve transplant

        Osaka hospital succeeds in novel heart valve transplant

        OSAKA, Japan - Osaka University professor Yoshiki Sawa (L) speaks at a press conference in Suita, Osaka Prefecture, on Oct. 27, 2014, about the first successful transplant surgery in Japan to replace a heart valve with a decelluraized one from a deceased donor. The 35-year-old patient (R) underwent the surgery at the Osaka University Hospital on Oct. 16 and has recovered steadily.
          Success of new treatment for pancreatitis

          Success of new treatment for pancreatitis

          OSAKA, Japan - Toshinori Ito, professor at Osaka University, Graduate School of Medicine, holds a press conference in Suita, Osaka Prefecture, on Aug. 21, 2013. Doctors at Osaka University Hospital in July successfully removed a chronically inflamed pancreas from a pancreatitis patient before separating the organ's insulin-producing islets and transplanting them back into the patient, marking a new form of treatment, Ito said.
            1st combined heart-lung transplant in Japan successfully held

            1st combined heart-lung transplant in Japan successfully held

            SUITA, Japan - Osaka University professor Yoshiki Sawa speaks at a news conference at the hospital in Suita, Osaka Prefecture, on Jan. 17, after successfully completing the first combined transplantation of a heart and lungs in Japan using organs from a man who had been certified as brain dead.